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Tissue-speciﬁc transcriptome proﬁling of Drosophila reveals
roles for GATA transcription factors in longevity by dietary
restriction
Adam J. Dobson 1, Xiaoli He1,3, Eric Blanc 2, Ekin Bolukbasi1, Yodit Feseha1, Mingyao Yang 1,4 and Matthew D. W. Piper1,5
Dietary restriction (DR) extends animal lifespan, but imposes ﬁtness costs. This phenomenon depends on dietary essential amino
acids (EAAs) and TOR signalling, which exert systemic effects. However, the roles of speciﬁc tissues and cell-autonomous
transcriptional regulators in diverse aspects of the DR phenotype are unknown. Manipulating relevant transcription factors (TFs)
speciﬁcally in lifespan-limiting tissues may separate the lifespan beneﬁts of DR from the early-life ﬁtness costs. Here, we
systematically analyse transcription across organs of Drosophila subjected to DR or low TOR and predict regulatory TFs. We predict
and validate roles for the evolutionarily conserved GATA family of TFs, and identify conservation of this signal in mice. Importantly,
restricting knockdown of the GATA TF srp to speciﬁc ﬂy tissues recapitulated the beneﬁts but not the costs of DR. Together, our data
indicate that the GATA TFs mediate effects of dietary amino acids on lifespan, and that by manipulating them in speciﬁc tissues it is
possible to reap the ﬁtness beneﬁts of EAAs, decoupled from a cost to longevity.
npj Aging and Mechanisms of Disease (2018)4:5; doi:10.1038/s41514-018-0024-4
INTRODUCTION
How can we counter ageing? Answering this question is a major
goal, as ever-increasing human lifespans outpace advances in
gerontology at great social, personal and ﬁnancial cost.1 Dietary
restriction (DR), a mild reduction in nutrient intake without
malnutrition, has the evolutionarily conserved capacity to improve
lifelong health, but at a cost of reduced biological ﬁtness and
vigour in youth.2 Despite having been discovered over 80 years
ago,3 the molecular mechanisms underpinning DR longevity
remain elusive. Elucidating these mechanisms could help isolate
the beneﬁts of DR from the corollary costs.
The lifespan beneﬁts of DR can be recapitulated by adjusting
the relative abundance of nutrients, without restricting the
amount of food consumed.4–6 In Drosophila, the ratio of dietary
sugar to yeast modulates lifespan, which is explained by essential
amino acids (EAAs) from the yeast.7 Importantly, this mechanism is
conserved in mice.8,9 EAAs up-regulate Target of Rapamycin (TOR)
signalling,10 and recent evidence indicates that the phenotype of
EAA-restricted Drosophila is recapitulated by pharmacologically
suppressing TOR.11,12 Understanding of how TOR curtails lifespan
is incomplete, although maintenance of proteome quality likely
plays a role.13–15 TOR also affects transcription,16–18 but to date
this output has been relatively poorly studied.
In Drosophila, transcriptomic responses to DR have been
characterised at the cellular and organismal levels.18 Characteris-
ing tissue-speciﬁc transcription may prove key to understanding
the nature of the trade-off between lifespan and ﬁtness imposed
by DR. EAAs are unusual nutrients since, by deﬁnition, they can be
neither synthesised nor stored. Therefore, their dilution in the diet
likely changes EAA levels uniformly across tissues. However, this
altered signalling may be lifespan-limiting in only a subset of the
affected tissues. In this case, longevity may be achieved by
reprogramming a DR-like signalling state speciﬁcally in those
tissues, whilst sparing other tissues of this manipulation would
promote their optimal function. Such a manipulation would offer
the beneﬁts of an EAA-replete diet, decoupled from its pernicious
lifespan-shortening effects. To date, there is evidence from
Drosophila that beneﬁts of DR are mediated at least in part by
the gut19 but not the ovary,20 suggesting that costs and beneﬁts
of dietary change can indeed be partitioned amongst tissues. We
have therefore focused on detailing systematically the tissue-
speciﬁc transcriptional changes induced by DR. We also assess the
extent to which DR-dependent transcriptional changes can be
explained by TOR signalling, by suppressing its activity in an EAA-
replete context, and measuring the degree to which the DR state
resembles the low-TOR state. We then predict which transcription
factors (TFs) mediate the observed transcriptional changes. We
predict and experimentally validate a role for GATA family of TFs in
DR longevity. Importantly, we conﬁrm that costs and beneﬁts of
DR can be partitioned amongst tissues by targeted TF
manipulation.
RESULTS
This study required precise dietary manipulations. We have
developed a semi-deﬁned Drosophila diet, which is optimal for
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early-life egg laying, in which 50% of dietary EAAs are provided as
a supplement to yeast-based medium.11 Lifespan can be extended
by omission of the EAA supplement (i.e., DR), but at a cost of
reduced egg laying. Thus, speciﬁc EAA dilution provides a precise
model to understand how dietary variation inﬂuences lifespan,
and the associated fecundity cost. Capitalising on this tool and
orthology between Drosophila and vertebrate organs, we char-
acterised EAAs’ effects on transcriptomes in the brain, fat body
(the analogue of the vertebrate liver and adipose), gut, ovary, and
thorax (which largely comprises muscle). This enabled us to
establish systematically the transcriptional effects of EAA dilution.
Tissue-speciﬁc signatures of DR
EAAs are required ubiquitously by Drosophila tissues, leading us to
expect that DR would orchestrate some global changes to gene
expression across tissues. We tested for such changes at a
transcriptome-wide scale. For each gene in each tissue, a measure
of average fold-change in expression upon DR was calculated, and
these values were clustered. Contrary to expectation, this analysis
did not discriminate any clear clusters (Fig. 1). This result indicated
that each tissue under study exhibited a broadly independent
transcriptomic response to DR.
To test the tissue-speciﬁcity of DR’s effect at a more granular
scale, we analysed differential gene expression independently in
each tissue. Differentially expressed (DE) genes were detected in
all tissues except the ovary (Table 1). Since DR reduces fecundity11
and ovary size (unpublished observation), we speculate that DR
down-regulates ovariole development, but without altering the
transcriptome of each ovariole, with the result that no change was
evident at the level of the whole ovary. Evaluating the overlap in
sets of DE genes amongst tissues revealed an overwhelmingly
tissue-speciﬁc effect of DR. No single gene was DE in all tissues.
Only ﬁve genes (Cyp9B2, tobi, CG10910, smp-30, CG14661) were
differentially expressed in more than two tissues, and pairwise
intersections of DE genes comprised only a small proportion of
overall transcriptional change (Supplementary Fig. 1, Supplemen-
tary data). Thus, DR had highly tissue-speciﬁc effects at the level of
gene expression.
Whilst the transcripts affected by DR were highly tissue-speciﬁc,
a possibility remained that these genes were involved in the same
processes, which could lead to equivalent physiological effects of
DR amongst tissues. To address this possibility, Gene Ontology
(GO) category enrichment was analysed for each tissue’s DE
genes. GO analysis revealed that the functional effects of DR were
also tissue-speciﬁc (Supplementary data). Thus, DR regulates
tissue-speciﬁc genes, associated with tissue-speciﬁc functions.
Overall, our transcriptome analysis indicated that the regulatory
effects of DR cannot be understood at the level of the whole
organism: instead, gene regulation and function of speciﬁc tissues
must be studied.
The DR regulon is enriched in the TOR regulon
Although the transcriptional signatures of DR were highly tissue-
speciﬁc, these changes were all due to the same upstream
stimulus (i.e., EAA dilution). This commonality left open the
possibility that similar cellular signalling pathways mediate DR’s
effects across tissues. The TOR pathway was a strong target for
such a pathway, given its evolutionarily conserved role in
signalling EAA availability. In our experimental paradigm, adding
rapamycin to the EAA-replete (control) medium promotes
phenotypic effects similar to those of DR,11 indicating that
rapamycin acts downstream of EAAs to promote DR-like signalling.
Therefore, we asked whether the transcriptional effects of
supplementing the EAA-replete diet with rapamycin were akin
to those of DR. These samples were collected in the same
experiment, facilitating their direct and quantitative comparison.
To address congruence of DR and rapamycin’s transcriptomic
effects, we isolated genes that were DE following rapamycin
feeding within each tissue, and examined overlaps within tissues
between sets of DR-regulated and rapamycin-regulated genes.
Overlaps were examined separately for up-regulated and down-
regulated genes, by applying hypergeometric tests. This compar-
ison could not be applied in the ovary, since DR did not cause
differential expression there. Rapamycin feeding affected gene
expression in all tissues (Supplementary Files). Furthermore,
signiﬁcant overlaps were detected with DR’s transcriptional
targets for all tissues, although we note that no genes were up-
regulated by both treatments in the brain, and in the fat body the
overlap for up-regulated genes was only marginally statistically
signiﬁcant (Table 2). As a second, broad-scale line of testing,
within-tissue correlations in changes to gene expression relative to
the EAA-replete control were evaluated, both at the level of the
whole transcriptome and just DE genes. This analysis revealed
correlated effects of DR and rapamycin feeding on DE genes (Fig.
2). Thus, rapamycin feeding not only shared transcriptional targets
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Fig. 1 Tissue-speciﬁc transcriptomic signatures of DR. The heatmap
shows transcriptome-wide log2 fold-changes in gene expression
induced by DR in each tissue, relative to the EAA-replete control
condition. Dendrograms show hierarchical clustering by Euclidian
distance
Table 1. Frequencies of differential gene expression in response to DR
per tissue
Tissue Sign of expression changea N. genes
Brain Up 60
Down 144
Fat Body Up 92
Down 334
Gut Up 9
Down 23
Ovary Up 0
Down 0
Thorax Up 138
Down 105
aRelative to EAA-replete control
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with DR, but the changes in expression of those targets are
quantitatively alike. This pattern was also evident transcriptome-
wide, for all tissues but the fat body (Fig. 2). Altogether, these
three different analyses show that, for at least one measure per
tissue, the transcriptional effects of dietary EAA dilution are
consistent with those of reduced TOR signalling, suggesting that
TOR signals downstream of DR to regulate gene expression.
Whilst DR and rapamycin had overlapping sets of transcriptional
targets, this overlap was not complete. To ask whether the
functions associated with reduced TOR were consistent with those
of DR, we tested the sets of rapamycin-regulated genes for GO
enrichment, and compared to the equivalent analysis of DR-
regulated genes. Similar GO categories were enriched in the genes
regulated by DR and rapamycin (Supplementary Files): For
example, in the brain, both DR and rapamycin regulated genes
involved in lipid metabolism and cold acclimation, whereas in the
fat body both treatments regulated genes involved in antimicro-
bial defence and vitellogenesis. Thus, rapamycin feeding and DR
are predicted to be associated with similar physiological changes.
Predicting lifespan-regulatory transcription factors
The major goal of our study was to leverage transcriptional data to
predict regulators of tissue-autonomous responses to DR.
Transcription factors (TFs) were of particular interest, because of
their capacity to coordinate multiple transcriptional targets to
effect a given physiological programme. We searched the genes
that were DE in response to DR for over-representation of motifs
known to bind TFs, using a tool that has previously been used to
successfully predict TFs that regulate ﬂy phenotype.21–23 This
analysis revealed a strong enrichment of motifs to bind GATA TFs
in all tissues (Supplementary Files). The enrichment was both
ubiquitous and highly statistically signiﬁcant. This association was
consistent with prior knowledge of the evolutionarily conserved
biology of these TFs: GATA factors play known roles in signalling
amino acid availability via TOR in evolutionarily diverse eukaryotes
(e.g., yeast24 and mosquitos25). Furthermore, GATA TFs have
known roles in signalling networks governing longevity in C.
elegans.26–28 Thus, the motif enrichment analysis provided a
logical result, associating DR-regulated transcripts to TFs with roles
in longevity and signalling EAA availability downstream of TOR.
Having established an association between DR and the GATA
binding element, we asked whether that signal could be
attributed to TOR. We repeated the motif analysis, focusing on
the transcriptional targets of rapamycin. Indeed, for all tissues,
genes that were DE following rapamycin feeding were also highly
enriched in the GATA element. Thus, our results suggested a
Table 2. Overlaps within tissues between DR and rapamycin-
regulated DE genes
Tissue Sign expression
changea
DR Rapamycin Overlap P-valueb
Brain Up 60 14 0 NA
Down 144 60 45 2.31e-83
Fat body Up 92 179 3 0.026
Down 334 110 43 9.12e-44
Gut Up 9 52 4 5.76e-11
Down 23 61 3 2.27e-6
Ovary Up 0 14 NA NA
Down 0 22 NA NA
Thorax Up 138 31 8 7.57e-12
Down 105 15 3 3.20e-6
aRelative to EAA-replete control
bHypergeometric test
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Fig. 2 Transcriptional effects of DR are consistent with reduced TOR signalling. Panels show log2 fold-changes in expression (lFC) relative to
the EAA-replete control in the DR and rapamycin-fed conditions for each tissue assessed (a - brain; b - fat body, c - gut, d - ovary and, e -
thorax). Slopes of lines show correlation coefﬁcients (Kendall’s Tau) for all genes in the transcriptome (green), or differentially expressed genes
only (pink). All correlations were statistically signiﬁcant (p < 0.05)
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circuit between circulating EAAs, cellular TOR signalling and the
GATA element.
Our results indicated highly tissue-speciﬁc transcriptional effects
of DR, all of which were associated with TOR/GATA signalling. How
could a ubiquitous EAA-TOR-GATA TF circuit achieve tissue-
speciﬁc transcriptional effects? One possibility is that the identity
of the GATA TF TOR signals through depends on the tissue in
question. The Drosophila genome encodes ﬁve GATA factors, and
plotting their expression in our transcriptome data revealed that,
indeed, each was expressed with its own pattern of tissue
speciﬁcity (Supplementary Fig. 2). These unique expression
proﬁles may combine with tissue-speciﬁc factors to translate
systemic signalling into a local gene expression language.
Altogether, our results outline a candidate mechanism in which
GATA factors act downstream of TOR in diverse tissues to
coordinate transcription.
GATA TFs are evolutionarily conserved in vertebrates including
mammals, playing important tissue-speciﬁc roles in development
and disease.29 DR and rapamycin promote lifespan of rodents, as
well as ﬂies, and the transcriptional effects of both interventions
have been established in murine liver by microarray. We asked
whether any evidence of GATA signalling could be recovered from
these data. Supporting our Drosophila data, three of the six GATA
TFs encoded by the mouse genome were differentially expressed,
either in response to DR or a combined treatment of DR and
rapamycin.30 Speciﬁcally, these microarray data suggested that,
relative to a condition of adlibitum feeding, GATAd1, GATA1 and
GATA6 were differentially expressed when mice were fed
rapamycin and DR food, and that DR alone was sufﬁcient to
explain this effect for GATAd1. Thus, the association between DR,
TOR signalling and GATA TFs appears to be conserved in a
vertebrate.
Functional roles for GATA factors in the DR phenotype
Our results predicted that the tissue-speciﬁc activity of GATA
factors regulated the effect of DR. We set out to test this
prediction for longevity and egg laying, focussing on two GATA
TFs in particular: srp and GATAe. srp was of interest because an
ortholog of srp in Aedes mosquitos, AaGATAa, links EAAs to
oogenesis via TOR and regulation of yolk protein precursors.25 This
appears to be an evolutionarily conserved function since, in
Drosophila, it has known roles in regulating oogenesis via yolk
proteins in the fat body,31 although this function has not yet been
connected to EAAs. Given this information and the effect of DR to
reduce egg laying, srp seemed a likely mediator of responses to
DR. The gut is another organ with major roles in the lifespan effect
of DR,19 so GATAe was selected for testing because of its roles in
the maintenance of intestinal stem cells,22 and the association
between their proliferation late in life and longevity.19 We tested
whether GATAe and srp in the gut and fat body, respectively,
mediated the effect of DR on lifespan and egg laying.
To manipulate GATAe and srp we expressed RNAi using the well-
characterised TiGS driver for the gut, and S1106 for the fat body,
which are activated by feeding an inducer, RU486. With these tools,
we asked whether expressing RNAi against GATAe in the gut or
against Srp in the fat body altered the phenotypic effect of DR. To
test these responses, we statistically modelled survival using Cox
proportional hazards (CPH) analysis, using the main effects of DR
and RU486, and a DR:RU486 interaction term as predictive variables.
In this paradigm a signiﬁcant interaction indicates that the effect
of DR is contingent on eating RU486, providing a sensitive analysis
without a need for pairwise comparisons between experimental
conditions.
In the absence of RU486, DR extended lifespan of TiGS; UAS-
GATAe[RNAi] ﬂies (Fig. 3a, Table 3). However, knocking down GATAe
altered this effect dramatically. Intestinal GATAe[RNAi] accelerated
the onset of mortality independent of diet but, remarkably,
reversed the effect of DR on lifespan: EAAs extended the lifespan
of ﬂies expressing intestinal GATAe[RNAi]. Whilst DR extended
Fig. 3 Tissue-restricted knockdown of GATAe and srp interact with dietary EAAs to determine egg laying and lifespan. Survival curves of ﬂies
fed EAA-replete or DR media, with/without expression of RNAi against GATAe in the midgut (a, TiGS, UAS-GATAe-RNAi), against srp in the fat
body (b, S1106, UAS-Srp-RNAi) Complementary egg laying indices are given in panels c–d (c, TiGS, UAS-GATAe-RNAi; d, S1106, UAS-Srp-RNAi).
Control medium was EAA-replete. Survival curves show proportion surviving over time. Box plots show medians, ﬁrst and third quartiles, and
whiskers extend 1.5 × interquartile range, with points showing individual data
Table 3. Cox proportional hazards analysis of DR × GATA RNAi lifespan
studies
Genotype Model term coef se(coef) z Pr( > |z|)
TiGS > GATAeRNAi EAAa −0.3096 0.1305 −2.372 0.0177
RUb −0.1733 0.13 −1.333 0.18245
EAA:RU 0.5756 0.1816 3.169 0.00153
S106 > SrpRNAi EAAa 0.35421 0.12675 2.794 0.0052
RUb 0.07606 0.12723 0.598 0.5499
EAA:RU 0.40604 0.1764 2.302 0.0213
DaGS > SrpRNAi EAAa 0.6607 0.1247 5.297 1.18E-07
RUb −0.3105 0.1305 −2.379 0.0173
EAA:RU −0.3834 0.1806 −2.123 0.0337
aExpressed as effect of adding EAAs, relative to DR medium
bExpressed as effect of adding RU486, relative to vehicle control
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median lifespan by 6% in the absence of RU486, it shortened
lifespan by 6% in the presence of RU486 (Table 4). CPH analysis
detected a signiﬁcant DR:RU486 interaction, conﬁrming that
intestinal GATAe[RNAi] signiﬁcantly altered DR’s effect on lifespan.
Thus, genetic intervention can reverse the sign of DR’s effect on
lifespan.
Knocking down Srp also supported a role for GATA TFs in DR
longevity. DR extended the lifespan of S1106/UAS-Srp
[RNAi]
ﬂies in
the absence of RU486 (Fig. 3b, Table 3) However, the effect of DR
on lifespan was contingent on Srp knockdown, revealed by a
signiﬁcant interaction of RU486 and DR in CPH analysis. Fat body
Srp[RNAi] extended median lifespan by 6% on EAA-replete media,
but by only 2% on DR media (Table 4). Thus, expressing this RNAi
seemed to extend lifespan only when ﬂies were fed the EAA-
replete medium, insulating them against the lifespan-shortening
effect of the diet. Thus, Srp appears to be required in the fat body
for the lifespan-shortening effect of dietary EAAs. Consistent with
the study of intestinal GATAe, this result suggests a role for GATA
TFs in DR longevity.
An ideal anti-ageing intervention should be effective without
biological costs in early life. Reduced egg laying is a well-
documented ﬁtness cost of DR in ﬂies. Having shown that the
beneﬁts of DR were contingent on GATA TFs, we tested whether
they also mediated this cost. We counted eggs laid in early life
(day 8 of adulthood) by the same ﬂies that were assayed for
survival, and analysed egg laying by ﬁtting the same terms as
were ﬁtted for survival in an ANOVA model. Consistent with
expectation, in the absence of RU486, DR reduced egg laying for
both S1106/UAS-Srp
[RNAi] and TiGS; UAS-GATAe[RNAi] ﬂies. However,
neither Srp[RNAi] nor GATAe[RNAi] reduced egg laying, nor interacted
with the effect of DR on egg laying (Fig. 3c,d, Table 5). Thus, the
roles of these GATA TFs in the gut and fat body on DR longevity
appears to be independent of DR’s fecundity effects.
The effect of GATAe and Srp on lifespan but not reproduction
indicated that DR’s inﬂuence on these life history traits are not
obligately coupled by signalling. We hypothesised that this could
be explained either by the effect of DR on egg laying and lifespan
being mediated by the same mechanism in distinct tissues, and,
additionally or alternatively, by distinct mechanisms in the same
tissues. Srp provided a system to test these models, since our
results showed that its expression in the fat body is required for
the full effect of DR on longevity but not fecundity; because it is
expressed in tissues other than the fat body (Supplementary Fig.
2); and because it is a known regulator of signals that promote
oogenesis.31 Therefore, we ubiquitously expressed the same UAS-
Srp[RNAi] construct as previously, under the control of the
Daughterless-GeneSwitch (DaGS) driver. We expected that this
systemic manipulation would interact with DR to determine
lifespan as previously, but with an additional fecundity effect. Such
an effect would indicate a role in reproduction in tissues other
than the fat body. Consistent with previous results, ubiquitous
Srp[RNAi] expression altered the effect of DR on lifespan, evidenced
by a signiﬁcant diet:RU486 interaction term in CPH survival analysis
(Fig. 4a, Tables 3–4). Thus, the effect of knocking down Srp in the
fat body had the same qualitative effect as ubiquitous knockdown.
We then examined the effect of ubiquitous Srp[RNAi] expression on
egg laying: An interaction between ubiquitous Srp[RNAi] and DR
would suggest a direct role for Srp in mediating diet’s fecundity
effects, whilst additive effects would indicate parallel roles.
Strikingly, ubiquitous Srp[RNAi] expression reduced fecundity by
an order of magnitude (Fig. 4b). This effect conﬁrmed a role for
Table 4. Median and maximum survival, DR × GATA RNAi lifespan
studies
Condition Lifespan Sample size
Genotype Medium Median Maximum Deaths Censored
TiGS >
GATAeRNAi
DR 89 103 126 36
Control 84 103 127 25
DR+ RU486 86 103 113 41
Control+
RU486
91 103 123 35
S106 > SrpRNAi DR 82 103 128 22
Control 77 100 142 9
DR+ RU486 84 103 120 31
Control+
RU486
82 103 130 18
DaGS >
SrpRNAi
DR 77 105 123 29
Control 72 105 137 9
DR+ RU486 84 107 115 36
Control+
RU486
79 105 123 28
Table 5. ANOVA of fecundity of ﬂies expressing RNAi against GATA
factors
Genotype Model term Df Sum Sq Mean Sq F value Pr( > F)
TiGS >
GATAeRNAi
EAAa 1 2.5697 2.56968 9.0973 0.003845
RUb 1 0.1918 0.19179 0.679 0.413429
EAA:RU 1 0.4408 0.44077 1.5604 0.216796
Residuals 56 15.8181 0.28247
S106 >
SrpRNAi
EAAa 1 2.4628 2.46276 29.873 1.15E-06
RUb 1 0.0821 0.08212 0.9961 0.3226
EAA:RU 1 0.027 0.02702 0.3278 0.5693
Residuals 55 4.5343 0.08244
DaGS >
SrpRNAi
EAA 1 1.9033 1.9033 19.36 5.14E-05
RU 1 18.8789 18.8789 192.034 < 2.20E-16
EAA:RU 1 0.0938 0.0938 0.9541 0.333
Residuals 54 5.3088 0.0983
aExpressed as effect of adding EAAs, relative to DR medium
bExpressed as effect of adding RU486, relative to vehicle control
Fig. 4 Systemic srp knockdown recapitulates beneﬁts of DR at
enhanced cost. Survival curves of ﬂies fed EAA-replete or DR media,
with/without expression of RNAi against srp under control of
daughterless GeneSwitch (a), with complementary egg laying indices
(b). Control medium was EAA-replete. Survival curves show
proportion surviving over time. Box plots show medians, ﬁrst and
third quartiles, and whiskers extend 1.5 × interquartile range, with
points showing individual data
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Srp in egg laying and indicated a strong biological cost of this
intervention, in contrast to the fat body-restricted knockdown.
However, there was no interaction between the effect of DR and
the effect of Srp[RNAi] (Table 5), consistent with Srp and dietary
EAAs affecting fecundity via parallel mechanisms. Thus, the effect
on longevity of knocking down Srp appears to be spatially discrete
from its fecundity effect, if limited to the fat body. Systemically, its
fecundity effect appears to be via a diet-independent mechanism.
Thus, whilst all three of the GATA knockdowns in this study
interacted with the effect of diet to determine lifespan, none of
them interacted with diet to determine fecundity.
DISCUSSION
DR improves lifelong health in a range of organisms, from yeast to
primates. A growing body of evidence shows the particular
importance of dietary nutrient balance for ageing, particularly
lowered protein:carbohydrate ratio,32 which implicates amino-acid
sensitive TOR signalling. A likely role of TOR was recently
underlined in Drosophila, by the demonstration that active TOR
is required for EAA enrichment to shorten lifespan.11 In the
present study we have conﬁrmed that the transcriptional effects
of DR are consistent with reduced TOR signalling. Moreover, our
results now identify a third level of regulation, implicating the
GATA family of TFs as mediators of dietary EAAs’ lifespan effects.
The evolutionarily conserved roles of this family of TFs in
signalling EAA availability, TOR signalling, oogenesis and tissue-
speciﬁc gene regulation, in addition to their regulation by DR and
rapamycin in murine liver, make them potential mechanisms of
longevity assurance worthy of further investigation. Roles of GATA
TFs in worm longevity have been established.26–28 Mice are also
long-lived when fed a restricted diet or rapamycin, and the ﬁnding
that GATA TFs are differentially regulated in mouse liver,30 reveals
evolutionary conservation and warrants study of their role in
mouse longevity.
The major motivation to understand how DR affects physiology
is to identify means to recapitulate its beneﬁts in later life without
associated biological costs, not to mention costs of an ascetic
lifestyle. Our results show that GATA TFs interact with diet to
determine lifespan, but not egg laying–the major ﬁtness cost of
DR in Drosophila. Furthermore, whilst ubiquitous expression of
Srp[RNAi] did affect egg laying, there was no interaction with diet: in
fact, none of the GATA TF knockdowns altered the effect of diet on
egg laying. Furthermore, restricting the Srp[RNAi] to the fat body
made the ﬂies long-lived without any effect on fecundity. Thus,
GATA TFs are candidates to relax tradeoffs between life-history
traits relevant to ageing, particularly when targeted speciﬁcally to
lifespan-relevant tissues, allowing the beneﬁts of feeding to
repletion whilst sparing costs to lifespan.
An important outcome of our analysis is the highly independent
transcriptional response of each tissue to DR. We hypothesised
that transcriptional programmes under tissue-speciﬁc control
would be sufﬁcient for longevity beneﬁts of DR, by disconnecting
lifespan-limiting pathologies and processes from the homoeo-
static regulation of other tissues. Importantly, the experiments
involving srp knock-down demonstrate that beneﬁts of DR can be
reaped by targeting transcription factors in speciﬁc organs,
making ﬂies constitutively long-lived even when eating an EAA-
replete diet. Whilst these results could possibly result from
stronger expression of the DaGS driver than the S1106 driver, this
seems an unlikely explanation given that both constructs
imparted a similar lifespan phenotype, but vastly different egg
laying phenotypes. Curiously, GATAe knockdown in the gut
changed the sign of the effect of DR on lifespan, suggesting
either a different optimal dietary balance in these ﬂies, or that
elevated EAAs rescued the pathological effects of gut-speciﬁc
GATAe knockdown. These experiments implicate GATA factors as
mechanistic links between diet, tissue-speciﬁc gene regulation
and lifespan.
The putative connections between lifespan, diet and GATA TFs
are entirely consistent with the evolutionarily conserved functions
of these proteins. The GATA TFs are an ancient family, with well-
characterised roles in development and nutrient signalling. In
multicellular differentiated organisms, GATA TFs are required in
the development of multiple tissue types, which in Drosophila
includes the heart,33 fat body34 and gut.35 However, their
functions in adulthood are poorly characterised. GATAe plays a
role in midgut homoeostasis in adult Drosophila, but it is unclear
where it integrates into broader midgut signalling networks.36,37
One of the better-described roles for GATA factors in adult animals
is in nutrient regulation of oogenesis in mosquitos.25,38–40 In Aedes
aegypti, oogenesis requires a blood meal, which contains the
mosquito’s only source of protein. Before feeding, egg production
is suppressed partly by a GATA TF repressing expression of the
major yolk precursor protein, Vg, in the fat body. After feeding,
TOR enhances expression of the transcriptional activator AaGATAa,
which de-represses Vg expression. This circuit appears to be at
least partially conserved, since srp regulates yolk protein expres-
sion in Drosophila,31 and our results show that its ubiquitous
knockdown strongly attenuates egg laying, although the absence
of an interaction with diet indicates a mechanism independent of
EAAs. Evidence from yeast suggests that the role of GATA factors
in regulating nitrogen metabolism is basal in Eukaryotes. In
Saccharomyces cerevisiae, selective amino acid catabolism is
controlled by a circuit known as Nitrogen Catabolite Repression:
when nitrogen availability supports only poor growth, TOR-
dependent nuclear localisation of a GATA TF activates expression
of genes involved in the transport and metabolism of less-
preferred nitrogen sources.24 Together, these data highlight
conserved connections between protein nutrition, growth, repro-
duction, TOR and transcriptional regulation by GATA TFs; and we
have now connected GATA TFs to longevity by DR. These roles are
entirely consistent with evolutionary theories that ageing is a
consequence of deleterious pleiotropy with mechanisms under
selection in early life.41
This study reveals tissue-speciﬁc patterns of transcriptional
regulation in response to the longevity-promoting restriction of
EAAs. The transcriptional effects of EAAs are associated with TOR
signalling and motifs to bind GATA TFs, and the tissue-speciﬁc
activity of GATA factors appears to dictate the effect of diet on
phenotype. Importantly, these experiments also suggest that the
costs and beneﬁts of dietary variation may be mediated by
different tissues, and therefore that beneﬁts may be reaped
without ﬁtness tradeoffs by tissue-speciﬁc genetic interventions.
The evolutionary conservation of GATA factors, of their connection
to regulating amino acid metabolism, and of the capacity of DR to
mediate lifespan extension, suggests that GATA factors may be
relevant to DR’s anti-ageing effect in a broad range of animals.
MATERIALS AND METHODS
Diets
Diets were prepared according to ref. 11 The base (1SY) medium contained
100 g/l autolysed yeast (MP Biomedicals, OH, USA), 50 g/l sucrose (Tate &
Lyle, London, UK), 15 g/l agar (Sigma-Aldrich, Dorset, UK), 30ml/l nipagin
(Chemlink Specialities, Dorset, UK), and 3ml/l propionic acid (Sigma-
Aldrich, Dorset, UK). The EAA-replete control medium comprised DR food
with an EAA supplement dissolved in pH 4.5 water (ﬁnal concentrations in
ﬂy media: L-arginine 0.43 g/l, L-histidine 0.21 g/l, L-isoleucine 0.34 g/l, L-
leucine 0.48 g/l, L-lysine 0.52 g/l, L-methionine 0.1 g/l, L-phenylalanine
0.26 g/l, L-threonine 0.37 g/l, L-tryptophan 0.09 g/l, L-valine 0.4 g/l: all
suppled by Sigma). EAA+ rapamycin food consisted of EAA-replete
medium with a rapamycin supplement (LC laboratories, MA, USA)
dissolved in ethanol, to a ﬁnal concentration of 200 µM in the diet. For
RNAi experiments, RU486 (Sigma M8046) dissolved in ethanol was added to
1SY or EAA food to a ﬁnal concentration of 200 µM.
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Fly culture
Outbred wild-type Dahomey ﬂies bearing the endosymbiont Wolbachia
were cultured on a 12:12 light cycle at 25 °C and 60% humidity, on 1SY
medium. For RNAi experiments, the TiGS, S1106 and DaGS drivers, and RNAi
constructs (UAS-srp[RNAi]: Vienna Stock Center #35578; UAS-GATAeTRiP:
Bloomington Stock Center #33748) were backcrossed into Dahomey ﬂies
bearing the w1118 mutation for at least six generations. UAS-GATAeTRiP
was backcrossed into this background by genotyping individual ﬂies by
PCR of the vector. S1106 drives in the fat body and anterior midgut,
however the effect of gut srp[RNAi] can be excluded owing to the absence
of srp expression in the gut (Supplementary Files). All ﬂies were maintained
at large population sizes to maintain outbred genetic diversity. For all
experiments, eggs were collected following an 18 h lay on grape juice agar,
added to bottles of 1SY at a standardised density and cultured to
adulthood. Newly emerged experimental females were mated on fresh
food for 48 h, lightly CO2 anaesthetised, then allocated to experimental
diets without males (10 females/vial). For egg laying and lifespan
experiments, survival was scored and ﬂies transferred to new media at
least three times per week. Egg laying was scored on day 8 after eclosion,
after 18 h egg laying. Phenotyping experiments were set up at different
times, one per experimental genotype, thus multiple experiments validate
the role of GATA TFs.
RNA sequencing
Tissues were dissected in ice-cold RNAlater solution, 6–10 h into the ﬂies’
light cycle, and frozen at −80 °C. RNA was extracted using the QIAGEN
total RNA isolation kit and quantiﬁed on an Agilent 2100 bioanalyser.
Sequencing was performed by the high throughput genomics services
center at the Huntsman Cancer Institute (University of Utah). Sample
concentration and purity of RNA was measured on a NanoDrop spectro-
photometer, and RNA integrity was assessed on an Agilent 2200
TapeStation. Illumina TruSeq libraries were prepared from this RNA with
the Illumina TruSeq Stranded mRNA Sample Prep kit and sequenced on an
Illumina HiSeq2000 101 v3 platform using paired-end sequencing.
Data analysis
Reads were aligned to D. melanogaster genome v6.19 using HISAT2 v2.1.0
and enumerated using featureCounts v1.6.0. Unmapped reads were
discarded. Enumerated reads were analysed in R and bioconductor
(3.3.1). Two gut samples from the DR condition were found to be internally
inconsistent with other gut samples, and also with gut transcriptomes from
external experiments. These samples were therefore excluded from further
analysis. Fold-changes in expression were calculated by DESeq2 (1.18.1).
Differential expression and fold-changes in expression were determined
for each tissue by DESeq2, by ﬁtting a model of the form
y  diet þ replicate
where y represented read counts of transcripti, replicate coded for
biological replicate with a three-level factor, and diet coded for whether
the ﬂies were fed control medium, DR medium, or rapamycin-
supplemented medium. Contrasts were then applied between the control
versus DR condition, and control versus rapamycin-fed condition. P-values
were corrected using independent hypothesis weighting, with base mean
of normalised counts as a covariate. Differential expression was considered
statistially signiﬁcant when corrected P-values were ≤ 0.01. Motif enrich-
ment amongst differentially expressed genes was analysed using i-Cis
target.42 Heatmaps were clustered by Euclidian distance metrics and
plotted using the heatmap.2 function from the gplots library, either on
fold-changes calculated by DESeq2, or median of variance-stabilised GATA
TF expression. Intersections between DE gene sets were visualised using
the upset library.43
Fly survival and egg laying data were analysed in R (v3.1.1). Survival data
were analysed using the coxph function from the survival library. Egg
laying data were normalised to number of ﬂies per vial and log-
transformed, and analysed by ﬁtting a linear model (ANOVA) using the
lm function. Both survival and egg laying data were analysed with a model
of the form
y  RU þ EAAsþ RU486 : EAAs
where y coded for survival or egg laying index, RU and EAAs for the
presence of RU486 and EAAs, respectively, and the interaction of the two.
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